Skip to main content
. Author manuscript; available in PMC: 2014 Mar 17.
Published in final edited form as: Cancer Chemother Pharmacol. 2010 Oct 20;68(2):293–300. doi: 10.1007/s00280-010-1478-7

Table 1.

Baseline patient characteristics

Characteristics N = 31
Age
 Median age (Range) 57 (36–75)
Gender, n (%)
 Male 17 (55%)
 Female 14 (45%)
ECOG PS
 0 12 (39%)
 1 19 (61%)
Patients receiving concurrent octreotide 12 (39%)
Primary disease site
 Lung—bronchial 4 (13%)
 Larynx 1 (3%)
 Stomach 1 (3%)
 Small bowel 17 (55%)
 Colon 2 (6%)
 Rectum 2 (6%)
Other/Unknown 4 (13%)
Prior cancer treatments
 Radiation 7 (23%)
 Cytotoxic chemotherapy 14 (45%)
 Alpha interferon 3 (10%)
 Other 15 (48%)
HHS Vulnerability Disclosure